SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " GLP " 375 found 🔀 AI-powered Shuffle
Employer healthcare expenses could spike 9.5% in 2027, pressured by GLP-1s
The benefits management company Aon said per-employee expenditures may rise about $19,000. While the broader economy is to blame, part of the rise can be attributed to the management of costly chronic conditions such as diabetes.
New study raises concerns over use of weight-loss drugs in elite sport
Researchers surveyed 114 sports medicine physicians from 38 countries, covering 93 different sports, to explore their views on athletes' use of GLP-1 drugs. Twelve percent said they were aware of athletes ...
Cancer doctor reveals 5 habits that may reduce disease risk and improve outcomes
A breast surgical oncologist shares five everyday strategies to reduce cancer risk, including how GLP-1 drugs like Ozempic could play a role.
Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling
The study, Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder (TAB), is a double-blind, randomized, placebo-controlled trial conducted through the National Institute on Drug Abuse’s Clinical Trials Network.
Mr. Gatti’s Pizza targeting return to Lubbock with new Family Entertainment Center
Mr. Gatti’s Pizza is targeting Lubbock as a potential spot for one of its new Family Entertainment Center locations.
Mr. Gatti’s Pizza targeting return to Lubbock with new Family Entertainment Center
Mr. Gatti’s Pizza is targeting Lubbock as a potential spot for one of its new Family Entertainment Center locations.
Could a drug designed for weight loss help athletes perform better?
GLP-1 weight-loss drugs can reduce weight and improve health, but could they also boost athletic performance?
GLP-1 weight loss drugs may boost results but raise oral health risks, dentist warns
Scientists solve the mystery of a brain “switch” that can trigger weight loss in opposite ways
Scientists have uncovered why two seemingly opposite ways of targeting the same brain receptor can both promote weight loss. In mice, activating the GIP receptor in the brainstem reduced appetite, while blocking it in the hypothalamus removed a kind of “brake” on fullness signals. The discovery helps explain why very different obesity drugs can achieve similar results and suggests that carefully combining GIP-targeting treatments with GLP-1 drugs like those related to Wegovy and Ozempic could produce stronger effects.
People are injecting fat from dead bodies. It’s called ‘zombie filler’
People are injecting fat from corpses and calling it "zombie filler." Doctors say the GLP-1 boom is driving the trend.
Ozempic may have revealed the brain’s hidden “craving center”
Ozempic-like drugs appear to weaken more than hunger—they may also reduce cravings for alcohol and other addictive substances. Scientists are increasingly tracing this effect to the lateral septum, a brain region that helps connect memories and surroundings with rewarding experiences. Packed with GLP-1 receptors, it may act as a crucial control point between thinking about a reward and feeling compelled to pursue it. The discovery could open new approaches to treating addiction as well as obesity.
Chrissy Metz Talks '& Juliet' and New Music, Shares Health Update
Chrissy Metz, “This is Us” and “The Hunting Wives” star, joins TODAY to open up for the first time about her decision to use GLP-1 medication and announce her new partnership with health care company Ro. Metz details why she was originally skeptical around weight loss drugs, shares how the medication has improved her life, dishes on performing in “& Juliet” and teases new music in the works.
Chrissy Metz Reveals She’s Taking a GLP-1 Drug: EXCLUSIVE
The actor discussed the mental and physical changes she’s noticed since partnering with Ro.
Kylo Peptides Expands Research Catalog to 36 Compounds as Peptide Science Enters a Record Growth Cycle
US research-peptide supplier scales its catalog against a market that analysts value between $47 billion and $141 billion, as peptides hold near 10% of new FDA drug approvals and GLP-1 use among American adults doubles in 18 months.Sheridan, Wyoming, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides, a US supplier of research-grade peptides, has expanded its catalog to around 36 peptides and research blends, the company announced today. The milestone lands during the most active growth period in t
GLP-1s Like Ozempic, Mounjaro May Lower Fracture Risk in Type 2 Diabetes
A new study has found that GLP-1 medications, like Ozempic and Mounjaro, may help reduce the risk of fragility-related fractures in people with type 2 diabetes.
This Week in Science: Mosquito Magnets, Bonus Benefits of GLP-1s, And More
Our weekly science news roundup.
Health Watch: Watch what you eat during food illness outbreaks; GLP-1s may help with dementia
Fact vs. Fiction: Separating the Myths from the Science Behind GLP-1 Medications
From social media claims to questions about safety, UConn Health OB/GYN and obesity medicine specialist Dr. Jason Schneider explains what patients should re ...
CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications
CVS Health® today announced a revamp of its weight management program, making it easier for eligible adults to access clinical care, navigate medication costs and get ongoing support for GLP-1 therapy.
As the GLP-1 Era Reshapes Weight Management, METAbiotics Launches with Science Designed to Support Long-Term Success
Today, Danone subsidiary The Akkermansia Company announced the U.S. launch of METAbiotics, a science-backed postbiotic brand developed from decades of pioneering research into Akkermansia muciniphila and designed to support sustained weight management and metabolic health.
For GLP-1 users, the in-store clothes shopping trip is back
Nora Nye, 58, is refreshing her wardrobe as she sizes down for the first time in over three decades after losing 80 pounds on weight-loss drug Mounjaro. Earlier this year, the Denver bankruptcy lawyer walked into a Macy's and found herself overwhelmed.
Hims and Hers accused of sharing GLP-1 patients' health data with Meta
The FTC conducted a nearly 3-year investigation before filing a lawsuit.
GLP-1s And Alcohol Addiction: Potential Benefits And What You Need To Know
GLP-1s And Alcohol Addiction: Potential Benefits And What You Need To Know
GLP-1s And Kidney Disease: Potential Benefits And What Experts Say
GLP-1s And Kidney Disease: Potential Benefits And What Experts Say
CASPR Ends Tenagrity Contract as Agenda Turns to Gambling
Center for Addiction Science terminates Tenagrity Solutions lobbying contract focused on GLP-1 drug access. Read the latest policy update.
FDA clears AI software for limiting false-positive ICM alerts
The cloud-based software from Implicity was built to help care teams reduce unnecessary alerts and prioritize patients who truly need care.
GLP-1s can affect how often some people need to take time off work, study finds
An analysis of employees in Denmark finds that diabetics taking Ozempic had fewer absences from work.
FedEx is chasing the GLP-1 boom. Why healthcare logistics means big business
The push marks FedEx's latest move to bolster business-to-business healthcare shipping, one of the four B2B verticals the company has prioritized.
Some people are getting shut out when it comes to GLP-1 drugs. Here’s why.
People with obesity in the United States are being sorted between haves and have-nots.
‘Ozempic face’ and hair loss: what evidence is there for weight-loss drug side-effects?
Research into GLP-1 medications is not always robust but complaints such as digestive problems are well known
Oral GLP-1 drugs may quiet the brain’s food craving circuit
Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding food cravings and potentially treating substance use disorder.
Harvard Pilgrim, Tufts Health Plan CEO talks GLP-1 weigh-loss drug coverage
A year in, Point32Health CEO sits down to discuss insurance premiums, drug prices, and layoffs.
MRI reveals muscle loss related to weight fluctuations
The research comes as popularity of weight loss medications has intensified in recent years, prompting concern about the loss of muscle mass among some GLP-1 users.
Why aren’t health insurers rushing to cover GLP-1 prescriptions for beneficial weight loss?
In theory, GLP-1 receptor agonist drugs like semaglutide and tirzepatide should save a lot of money for the health insurers that pay for them. As it turns out, the lived reality is not keeping pace with the idealistic expectation.
3 newsy must-reads on AI in healthcare (plus 3 bonus picks)
1.) Some clinical AI has a fuzzy ROI. That doesn’t mean it shouldn’t be reimbursed. 2.) What makes biomedical research different from other sectors where AI has been quickly adopted? 3.) Unmoved by enthusiasm, health execs are making AI decisions around organizational priorities.
Novo Nordisk sues GLP-1 rival Eli Lilly over claims of false advertising
Novo Nordisk filed a lawsuit claiming Eli Lilly ran “false and materially misleading” advertisements that ignore recent data. According to Lilly, though, its message is "truthful" and "grounded in the most direct scientific evidence available."
Roundup: LNG exports / Prairieville market / GLP-1 rivalry
Predicted to double: U.S. LNG exports are expected to nearly double by 2031, becoming the country’s second-largest net export industry and contributing an estimated $1.4 trillion to the economy. The growth is driven by abundant shale gas supplies, major Gulf Coast investments and rising global demand, with LNG exports projected to support hundreds of thousands […]
Does Medicare Cover GLP-1s For Weight Loss? What To Know In 2026
Does Medicare Cover GLP-1s For Weight Loss? What To Know In 2026
ESPN to reportedly lay off Tom Pelissero, Karl Ravech
Karl Ravech joined ESPN back in 1993.
HHS vaccine committee quietly gets new charter
Lax clinical oversight for online GLP-1 prescriptions, proposed financial help for people who want to quit smoking, and more health news
What really happens at a GLP-1 retreat? I went to find out.
There’s a lot to consider before starting or stopping a GLP-1 medication. This wellness retreat lays it all on the table.
Opinion | Double standard over GLP-1 drugs hits women especially hard
Women experience the effects of obesity in many ways, including heart disease, certain cancers, fertility challenges, maternal health complications, and more severe menopause symptoms.
Weight-loss drugs may improve job prospects and dating odds for one group
A weight-loss specialist says GLP-1 results boost confidence in job interviews and dating, but the study found no clear improvement in well-being.
Does stopping GLP-1s make you gain the weight back? What the science says
A trio of recent studies suggest that some people can keep the weight off.
Jillian Michaels warns against social media health advice as ‘healthmaxxing’ trend goes viral
‘Keeping It Real’ podcast host Jillian Michaels discusses the viral ‘healthmaxxing’ trend and GLP-1 drugs on ‘Fox & Friends.’
Cutting GLP-1 coverage may cost UVM Health more than it saves
UVM Health expects to save $19 million a year by cutting GLP-1 coverage for employees. But does that figure account for the medical costs patients avoid once the treatment works?
Asheville wellness business owner accused of illegally prescribing GLP-1 drug
The owner of an Asheville wellness business is facing 10 felony charges after investigators accused her of diagnosing clients without a medical license in N.C.
GLP-1s are latest wedding trend that has serious implications
Doctors worry the drugs are becoming a wedding fad as online prescribing makes them easier to obtain.
Waiting for insurance coverage for GLP-1s for weight loss? Keep waiting.
The corporations that pay for private employee health insurance are not ready to swallow the high costs of the enormously popular drugs, said the CEO of CVS Health.
Defying skeptics of women in science, she pioneered GMO research in plants
Mary-Dell Chilton, who has died at 87, led a team credited with developing the first genetically modified plant.
GLP-1 drugs linked to long-term benefits for PAD patients
PAD patients treated with GLP-1 receptor agonists lived longer, stayed out of the hospital more and experienced fewer amputations than those given metformin.
GLP-1 drug popularity is outpacing the science, Madison doctor says
Dr. David Harris at UW-Madison says weight loss drugs like Ozempic, Wegovy and Zepbound are safe, so long as patients get the medications from doctors.
Impressive growth of Eli Lilly's obesity business is coming from all over the world
Eli Lilly's international GLP-1 business is booming, giving investors another reason to stick with the stock.
Surprising Mental Health Effects of GLP-1 Weight Loss Drugs
GLP-1 medications may be used to treat select psychiatric disorders.
Dr Oz links obesity to chronic disease surge, says GLP-1s can 'jumpstart' better health
Dr. Mehmet Oz backs GLP-1 weight loss medication, but stresses that diet and exercise remain essential, calling obesity the top driver of healthcare costs.
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it
Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.
Ipsos poll offers new snapshot of Americans' views on health care and GLP-1 drugs
These 10 Medications May Raise Your Risk of Heat-Related Illness
As summer temperatures climb, so do the risks of heat-related illnesses, particularly for those who take certain medications, such as GLP-1s, diuretics, antidepressants, and beta-blockers. Here's what you need to know to stay safe.
Karpa Health Launches Turnkey Nationwide Telehealth Platform as GLP-1, Peptide, and Hormone Demand Accelerates
The all-in-one platform helps entrepreneurs, clinics, med spas, gyms, and wellness brands launch cash-pay telehealth programs nationwide. TAMPA, FL / ACCESS Newswire / July 3, 2026 / Karpa Health today announced the general availability of its turnkey ...
Dr. Oz on Medicare covering weight loss drugs, America's health innovation
Dr. Mehmet Oz discusses health innovation for America's 250th birthday, highlighting a new initiative where Medicare will cover GLP-1 weight loss medications for $50 a month, aiming to reduce health complications.
Health or Hoax?
Although GLP-1s may cultivate confidence and belonging among gay and bisexual men, they can also reinforce idealized body types that can be unhealthy and socially exclusionary.
What older adults need to know before taking a GLP-1 medication to lose weight
Starting Wednesday, millions of Medicare-qualifying adults will have access to popular medications for weight loss at deep discounts through a temporary federal program called the Medicare GLP-1 Bridge.
5 things to know about an emerging drug-resistant fungus now putting hospitals at risk of outbreaks
Memo to health execs: If your hospital hasn’t had a C. auris scare yet, odds are quite high that it soon will.
Can GLP-1 medications improve health in people with Type 2 diabetes and PAD?
Research Highlights: GLP-1RA (glucagon-like peptide-1 receptor agonist) medications, which are prescribed to treat Type 2 diabetes and to help with weight loss, were found to reduce the number of deaths, amputations and hospitalizations among people...
Ozempic Might Be Making Your Team Less Driven. Here’s the Science
New reports on GLP-1 drugs and the brain’s “wanting” system have direct implications for how leaders motivate, reward, build teams, and sustain culture.
Top GLP-1 prescription indications include sleep apnea, depression and kidney disease, study finds
A report from Trilliant Health looking at payer data found that, as prescriptions for the popular weight loss drugs spike, so rises the number of approved benefits.
Unredacted comments from California hospital lawsuits show stunning admissions and a 'forced' McKinsey collaboration
Who controls the Medicaid market, GLP-1 usage and pizza household costs, and more from Health Care Inc.
GLP-1s 101: What the science says about weight loss, side effects, safety
We asked Stanford Medicine experts to break down everything you need to know about the drugs known as GLP-1s, semaglutide, Ozempic, Wegovy, Zepbound and many more.
Medicare is about to cover GLP-1 drugs for weight loss. Here’s what to know.
The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers have not been disclosed.
Could GLP-1 Drugs Help You Live Longer?
Experts are intrigued by the theory. Here’s what early research suggests.
Could GLP-1 Drugs Help You Live Longer?
Experts are intrigued by the theory. Here’s what early research suggests.
Americans keep poisoning themselves with semaglutide, other weight loss drugs
These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021.
Medicare will soon offer some older Oregonians weight loss drugs for $50 a month. Here’s how it works.
Medicare has long excluded coverage of GLP-1s prescribed solely for weight loss.
Microsoft quietly extends Windows 10's extra security updates program for free: Users can now stay on Windows 10 until October 2027 securely
Windows 10's ESU program has been quietly extended by an extra year, now ending on October 12, 2027 instead of October 2026.
GLP-1 and reduced cancer risk discovery earns UT Health San Antonio fellow prestigious Helio NextGen Disruptor Award
Colton Frisco Jones, MD, a 2nd-year fellow at the Mays Cancer Center at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual meeting in Chicago.
U.S. health spending rose sharply in 2025, thanks to GLP-1 use and more care
People are getting more care and using lots of GLP-1 drugs, fueling a sharp increase in health care spending.
Science in Seconds: Improving GLP-1
A UConn Health researcher explains how her lab is focusing on how GLP-1 medications affect the brain and how they can be improved for the future
People on GLP-1 medications are exercising less
A new study found that people using weight-loss drugs are doing less exercise, despite feeling healthier. Here's how muscle mass and bone density are affected.
Trouble getting weight loss drugs covered by insurance? Here's what to know
If your doctor prescribes a GLP-1 medication for weight loss but your insurance won't cover it, you have options.
CVS Pharmacy® expands GLP-1 support to lower costs, improve access, and help patients stay on therapy
New $50 monthly copay for eligible Medicare patients, one-on-one pharmacist guidance, and over-the-counter products to help manage common side effects available to support patients
Should everyone be on GLP-1s? What science actually tells us (and doesn't) about the broader health benefits
The laundry list of possible health benefits from GLP-1 drugs seems to get longer by the day, from cancer prevention to combating addiction. But while there’s no question these medications show immense promise beyond their use for diabetes and weight loss, science is still catching up.
Popular weight-loss drugs linked to unexpected male fertility benefit
GLP-1 drugs like semaglutide and liraglutide do not appear to suppress male hormones and may boost fertility in obese men, new research suggests.
Ozempic changed obesity treatment, but experts say the real revolution is next
The obesity treatment landscape is changing fast, with GLP-1 drugs opening the door to more effective care than ever before. Experts now envision a future where medications, minimally invasive procedures, surgery, and precision medicine work together to deliver better long-term results.
U.S. scientific instruments in oceans off Alaska and elsewhere to remain in place
After a public outcry and a unanimous Senate vote, the National Science Foundation dropped plans to remove parts of the Ocean Observatories Initiative system.
Ozempic and Wegovy linked to surprising drop in violent behavior
A Rutgers study suggests GLP-1 drugs such as Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior. The surprising finding hints that these medications could affect how people act on impulses, though researchers stress that cause and effect have not been proven.
Ozempic users may be making a major weight-loss mistake, new study suggests
New research finds GLP-1 users significantly reduced physical activity, with daily steps and exercise declining after starting a weight loss medication.
Central Florida counselor discusses connection between mental health and GLP-1 weight-loss drugs
Licensed mental health counselor Shantala Boss explores the connection between GLP-1 medications, disordered eating, and body image concerns.
GLP-1 and weight-loss drugs: How fast-track health solutions are reshaping FMCG
GLP-1 weight-loss drugs are reshaping FMCG as health, body control, and self-optimization trends redefine consumer behaviour across Europe.
Why healthcare stocks are primed to outperform the market: 2 firms
UBS listed three reasons they like the sector, starting with GLP-1 weight-loss drugs.
GLP-1s may help –– not harm –– male fertility
Not only are GLP-1 medications likely not harmful to male fertility, but they may help improve testosterone levels, sperm health and production, study says.
GLP-1s may help –– not harm –– male fertility
Not only are GLP-1 medications likely not harmful to male fertility, but they may help improve testosterone levels, sperm health and production, study says.
Middle-aged adults taking GLP-1s for obesity can save over $192K on lifetime medical costs, higher if they don’t have college degrees, new study finds
The National Bureau of Economic Research paper's lead author hopes putting a dollar value on the benefits of GLP-1s will lead to better access
People taking GLP-1 weight loss drugs like Ozempic started moving less
People taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound may be losing pounds, but they could also be moving less. Researchers analyzing Fitbit data found that daily step counts and exercise levels dropped after people started these medications, despite successful weight loss. Because the drugs can reduce muscle mass along with fat, the decline in physical activity raises concerns about preserving strength and long-term health.
GLP-1 Drugs May Protect Against Cancer— Here’s What That Means For Public Health
New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.
Shaquille O'Neal says he's taking GLP-1s. What it says about body image.
Shaquille O’Neal is the latest among a growing number of celebrities to disclose their usage of GLP-1 medications. What does it mean for body image?
US Workers’ Health Insurance Costs Set to Rise, Survey Finds
Employers say higher prices are forcing them to raise premiums. Some will also stop covering GLP-1s.
Penn study finds GLP-1 use associated with lower breast cancer risk; researchers to launch clinical trial
Women in the study who were obese and taking GLP-1 weight loss medications were 30% less likely to develop breast cancer than other women.
Serena Williams and the coming reckoning with GLP-1s and performance enhancement
GLP-1s are not prohibited; the way they work means they might never be. Anti-doping authorities are still monitoring how athletes use them.